Loading company…
Scailyte AG develops precision medicine diagnostics from single-cell data, based in Basel, Switzerland.
Based in Basel, Switzerland, and founded in 2017 by CEO Peter Nestorov, Daniel Sonnleithner, Dennis Gohlsdorf and Manfred Claassen, Scailyte AG (Scailyte) finds predictive biomarkers and designs companion diagnostics in immunology and oncology using single-cell omics and AI. Its ScaiVision platform supports precise biomarker identification. Hera Biotech, Inc. agreed to acquire the company in January 2024, and the company plans to use the proceeds to expand its endometriosis diagnostic programs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in